A new era in pain management
We are leading the charge in transforming how the world treats pain. In addition to our best-in-class portfolio, we’re driving awareness and adoption of safer, non-opioid pain management options through education, advocacy and access.
Spotlighting the surgical gateway
We were the first company to highlight the connection between surgery and opioid overprescription. We launched several national campaigns designed to raise public awareness about the risks of opioids and highlight the availability of and expanded access to non-opioid options for postsurgical pain. This included producing an award-winning documentary that reveals how postsurgical opioid use can inadvertently lead to addiction, emphasizing the need for safer alternatives.
Empowering shared-decision making
Through patient-focused initiatives, we drive change by empowering patients and caregivers to confidently discuss non-opioid pain management options with their providers. We support and share the knowledge and tools needed to explore treatment options and develop effective, personalized pain plans.
Expanding access to non-opioid options
Advocating for non-opioid access in the U.S.
We believe everyone deserves access to safe pain management options. That’s why we proudly provided the seed funding to help establish Voices for Non-Opioid Choices, a nonpartisan coalition of more than 130 organizations dedicated to preventing opioid addiction before it starts. Voices is now the leading advocacy group on Capitol Hill for reimbursement policy reform, driving legislative changes to expand patient access to non-opioid options, including the recently passed NOPAIN Act.
Supporting global pain relief efforts
Around the world, we strive to make non-opioid pain relief more accessible by funding medical missions and donating therapies that help patients recover safely after surgery. Through these efforts, we aim to ensure that safe, effective pain management options are available to patients no matter where they live.
On our medical mission to Honduras, our team operated on over 60 people with EXPAREL with perfect success. EXPAREL was directly responsible for not only eliminating the predictable postoperative pain, but actually enabling us to do some surgeries we would have otherwise not been able to do at all because of the complete lack of adequate alternative postoperative pain control options.”